Veracyte, Inc. (VCYT)
Key Executives
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Marc A. Stapley | CEO & Director | 1.25M | -- | 1970 |
Ms. Rebecca Chambers | Executive VP & CFO | 772.41k | -- | 1979 |
Ms. Annie McGuire | Executive VP, General Counsel & Chief People Officer | 633.65k | -- | 1981 |
Mr. Jonathan Wygant | VP & Chief Accounting Officer | -- | -- | 1971 |
Mr. Steven French | Senior VP & Chief Information Officer | -- | -- | -- |
Dr. Phillip G. Febbo M.D. | Chief Scientific & Medical Officer | -- | -- | 1966 |
Ms. Karen Possemato | Senior Vice President of Corporate Marketing, Communications & Commercial Operations | -- | -- | -- |
Mr. Robert Brainin | Executive VP & Chief Business Officer | -- | -- | 1971 |
Dr. John Leite Ph.D. | Chief Commercial Officer for CLIA Business | -- | -- | -- |
Ms. Corinne Danan | Senior Vice President | -- | -- | -- |
Veracyte, Inc.
- Sector:
- Healthcare
- Industry: Diagnostics & Research
- Full Time Employees:
- 815
Description
Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; Percepta Nasal Swab Test for lung cancer diagnosis; and Envisia Genomic Classifier for diagnosing interstitial lung disease, including idiopathic pulmonary fibrosis. It is also developing Envisia Classifier, the nCounter analysis system; and LymphMark for lymphoma subtyping test. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
Corporate Governance
Recent Events
- Apr 17, 20248-K/A: Corporate Changes & Voting MattersSee Full Filing
- Feb 29, 202410-K: Periodic Financial ReportsSee Full Filing
- Feb 22, 20248-K: Corporate Changes & Voting MattersSee Full Filing
- Feb 13, 20248-K: Corporate Changes & Voting MattersSee Full Filing
- Feb 06, 20248-K: Corporate Changes & Voting MattersSee Full Filing